Literature DB >> 3804446

Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani.

M Olivier, C E Tanner.   

Abstract

Many studies have demonstrated differences in the resistance of strains of mice to infection by Leishmania donovani, Salmonella typhimurium, and Mycobacterium bovis BCG; this resistance/susceptibility phenotype seems to be controlled by a single gene. The present study investigated the susceptibility of liver, lung, peritoneal, and spleen macrophages to infection by L. donovani promastigotes in vitro; the objective was to determine if the susceptibility of animals was expressed by their macrophages when infected in vitro. This study indicated that the Lsh phenotype was only expressed by liver macrophages. The liver macrophages of the susceptible C57BL/6J strain were significantly more phagocytic than those of the resistant C57L/J strain; infection affected the phagocytic activity of the macrophage population. These results indicated that only liver macrophages can express the Lsh gene. Recognition of expression is in part due to its effect on the phagocytic activity of the macrophages.

Entities:  

Mesh:

Year:  1987        PMID: 3804446      PMCID: PMC260352          DOI: 10.1128/iai.55.2.467-471.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse.

Authors:  D J Bradley; B A Taylor; J Blackwell; E P Evans; J Freeman
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  Variation in susceptibility of mouse strains to Leishmania donovani infection.

Authors:  D J Bradley; J Kirkley
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

3.  Simplified defined media for cultivating Leishmania donovani promastigotes.

Authors:  R F Steiger; C D Black
Journal:  Acta Trop       Date:  1980-06       Impact factor: 3.112

4.  Genetically determined susceptibility to Leishmania tropica infection is expressed by haematopoietic donor cells in mouse radiation chimaeras.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

5.  Genetically determined differences in antibacterial activity of macrophages are expressed in the environment in which the macrophage precursors mature.

Authors:  P A Kongshavn; C Sadarangani; E Skamene
Journal:  Cell Immunol       Date:  1980-08-01       Impact factor: 4.868

6.  Genetic regulation of resistance to intracellular pathogens.

Authors:  E Skamene; P Gros; A Forget; P A Kongshavn; C St Charles; B A Taylor
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

7.  Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1?

Authors:  J E Plant; J M Blackwell; A D O'Brien; D J Bradley; A A Glynn
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

8.  Comparative studies of inflammatory responses in susceptible and resistant mice infected with Giardia muris.

Authors:  M Belosevic; G M Faubert
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

9.  The natural resistance of radiation chimeras to S. typhimurium C5.

Authors:  C E Hormaeche
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

10.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

View more
  12 in total

1.  Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene.

Authors:  Y Goto; E Buschman; E Skamene
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani.

Authors:  Jean-François Marquis; Isabelle Hardy; Martin Olivier
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.

Authors:  M E Proulx; A Désormeaux; J F Marquis; M Olivier; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.

Authors:  Leonid Kagan; Pavel Gershkovich; Kishor M Wasan; Donald E Mager
Journal:  AAPS J       Date:  2011-03-23       Impact factor: 4.009

6.  Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Authors:  R Appelberg; J Pedrosa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model.

Authors:  Ellen K Wasan; Pavel Gershkovich; Jinying Zhao; Xiaohua Zhu; Karl Werbovetz; Richard R Tidwell; John G Clement; Sheila J Thornton; Kishor M Wasan
Journal:  PLoS Negl Trop Dis       Date:  2010-12-07

Review 8.  Determinants for the development of visceral leishmaniasis disease.

Authors:  Laura-Isobel McCall; Wen-Wei Zhang; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

9.  Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.

Authors:  E Medina; R J North
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.

Authors:  S Vidal; M L Tremblay; G Govoni; S Gauthier; G Sebastiani; D Malo; E Skamene; M Olivier; S Jothy; P Gros
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.